As we find that TRAIL does not only induce cytokines in lung cancer cell lines but also in colorectal and pancreatic cancer lines, it is likely that the principal mechanism of a TRAIL-generated, tumor-supportive immune environment may also apply to other cancer types. The gene discussed is TNFSF10; the disease is pancreatic neoplasm.